Form 4: Rocket Pharmaceuticals Executive Sells Shares to Cover Tax Obligations

John Militello, Vice President of Finance, Treasurer, and Principal Accounting Officer of Rocket Pharmaceuticals, sold 833 shares of common stock on April 22, 2024, to cover tax withholding obligations related to vesting RSUs.

Summary

• On April 22, 2024, John Militello, an officer at Rocket Pharmaceuticals, sold 833 shares of common stock.
• The sale was executed at a price of $22.87 per share.
• The transaction was conducted to cover tax withholding obligations associated with the vesting of Restricted Stock Units (RSUs).
• Following the transaction, Militello directly owns 54,406 shares of Rocket Pharmaceuticals common stock.

Sentiment

Score: 6

Explanation: The sentiment is neutral. The transaction is a routine sale of shares to cover tax obligations, which is a common practice and doesn't necessarily reflect a positive or negative outlook on the company.

Industry Context

Sales of shares to cover tax obligations upon vesting of RSUs are a common practice among company executives and are generally not indicative of a negative outlook on the company's future.

Stakeholder Impact

• The sale of shares by an officer could have a minor impact on shareholder sentiment, but is unlikely to be significant given the reason for the sale.

Key Dates